Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Middle East and Africa Diabetic Assays Market - Industry Trends and Forecast To 2027

  • DAT3384284
  • 80 Pages
  • November 2019
  • Pharmaceuticals
Download Sample    Get Discount   
 
Middle East and Africa diabetic assays market is projected to register a substantial CAGR in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027

Market Segmentation:

By Type (Assays, Devices, Consumables), Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), Deployment (Automated, Manual), End User (Hospitals, Clinics, Diagnostic Laboratories, Academic Institutes, Others), Distribution Channel (Direct, Indirect), Country (Saudi Arabia, South Africa, Egypt, U.A.E., Israel and Rest of Middle East & Africa)

Some of the major factors contributing to the growth of the market are:

• Growing government initiative regarding diabetic diseases

• Rising awareness among the people

Market Players:

The key market players for Middle East and Africa diabetic assays market are listed below:

• Abbott

• Danaher

• Merck KGaA

• SIEMENS HEALTHINEERS AG

• Bio-Rad Laboratories, Inc.

• DiaSorin S.p.A.

• EKF Diagnostics

• DRG INSTRUMENTS GMBH

• PTS Diagnostics

• Ortho Clinical Diagnostics

• Medipan GmbH

• Diagnostic Automation/Cortez Diagnostics Inc.

• Diazyme Laboratories, Inc.

• Ethos Biosciences, Inc.

• BioAssay Systems

• Tosoh Corporation

• Abnova Corporation

• Monobind Inc

• ORGENTEC Diagnostika GmbH

• ALPCO

TABLE OF CONTENTS

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.10 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING PREVALENCE OF DIABETES

3.1.2 INCREASING GERIATRIC POPULATION

3.1.3 TECHNOLOGICAL ADVANCEMENT

3.1.4 AVAILABILITY OF REIMBURSEMENT

3.1.5 INCREASING DEMAND FOR THE HAND-HELD DIAGNOSTIC DEVICES

3.2 RESTRAINT

3.2.1 PRODUCT RECALL

3.2.2 HIGH COST OF THE ASSAY

3.2.3 IMPLEMENTATION OF EXCISE DUTY BY THE U.S. GOVERNMENT

3.3 OPPORTUNITIES

3.3.1 RISING GOVERNMENT INITIATIVES

3.3.2 STRATEGIC INITIATIVE BY MARKET PLAYERS

3.3.3 RISE IN AWARENESS AMONG THE POPULATION

3.3.4 GROWING HEALTHCARE INFRASTRUCTURE

3.4 CHALLENGES

3.4.1 STRINGENT REGULATION

3.4.2 LACK OF SKILLED PROFESSIONALS

3.4.3 LOW PENETRATION IN DEVELOPING ECONOMIES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 REGULATORY PROCEDURE

7 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY TYPE

7.1 OVERVIEW

7.2 ASSAYS

7.2.1 DIABETES DIAGNOSTICS GLUCOSE ASSAY

7.2.2 DIABETES DIAGNOSTICS HBA1C ASSAY

7.3 DEVICES

7.3.1 ANALYZERS

7.3.2 SOFTWARE

7.4 CONSUMABLES

7.4.1 TEST STRIPS

7.4.2 REAGENT

7.4.3 OTHERS

8 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE

8.1 OVERVIEW

8.2 TYPE 2 DIABETES

8.3 TYPE 1 DIABETES

8.4 GESTATIONAL DIABETES

9 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT

9.1 OVERVIEW

9.2 AUTOMATED

9.3 MANUAL

10 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 DIAGNOSTIC LABORATORIES

10.4 CLINICS

10.5 ACADEMIC INSTITUTES

10.6 OTHERS

11 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT

11.3 INDIRECT

12 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY GEOGRAPHY

12.1 MIDDLE EAST & AFRICA

12.1.1 SAUDI ARABIA

12.1.2 SOUTH AFRICA

12.1.3 EGYPT

12.1.4 U.A.E.

12.1.5 ISRAEL

12.1.6 REST OF MIDDLE EAST & AFRICA

13 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

14 COMPANY PROFILE

14.1 BIO-RAD LABORATORIES, INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 ABBOTT

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENT

14.3 SIEMENS HEALTHINEERS AG

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENT

14.4 DANAHER

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENT

14.5 DIASORIN S.P.A.

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENT

14.6 ABNOVA CORPORATION

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENT

14.7 ALPCO

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 BIOASSAY SYSTEMS

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 DIAGNOSTIC AUTOMATION/CORTEZ DIAGNOSTICS INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENT

14.10 DIAZYME LABORATORIES, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 DRG INSTRUMENTS GMBH

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 EKF DIAGNOSTICS HOLDINGS PLC

14.12.1 COMPANY SNAPSHOT

14.12.2 REVENUE ANALYSIS

14.12.3 PRODUCT PORTFOLIO

14.12.4 RECENT DEVELOPMENT

14.13 ETHOS BIOSCIENCES, INC.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 MEDIPAN GMBH

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 MERCK KGAA

14.15.1 COMPANY SNAPSHOT

14.15.2 REVENUE ANALYSIS

14.15.3 PRODUCT PORTFOLIO

14.15.4 RECENT DEVELOPMENT

14.16 MONOBIND INC.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENT

14.17 ORGENTEC DIAGNOSTIKA GMBH

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENT

14.18 ORTHO CLINICAL DIAGNOSTICS

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENT

14.19 PTS DIAGNOSTICS (A SUBSIDIARY OF SANNUO BIOSENSOR CO., LTD.)

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENT

14.20 TOSOH CORPORATION

14.20.1 COMPANY SNAPSHOT

14.20.2 REVENUE ANALYSIS

14.20.3 PRODUCT PORTFOLIO

14.20.4 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

LIST OF TABLES

TABLE 1 CANADA REIMBURSEMENT LIMITS FOR TEST STRIPS FOR EACH 365-DAY PERIOD

TABLE 2 IRELAND REIMBURSEMENT FOR TEST STRIPS

TABLE 3 COMPARISON OF NGSP-CERTIFIED A1C POC DEVICES

TABLE 4 MEDICAL DEVICE RECALLS

TABLE 5 BIO-RAD LABORATORIES, INC. (U.S.) DIABETIC ASSAYS PRICES

TABLE 6 PRIVATE-SECTOR R&D INVESTMENT IN MEDICAL DEVICES AND EQUIPMENT ( IN USD MILLION)

TABLE 7 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 8 DIRECT COSTS OF DIABETES (IN USD)

TABLE 9 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA ASSAYS DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA DEVICES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA TYPE 2 DIABETES DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA TYPE 1 DIABETES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA GESTATIONAL DIABETES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA AUTOMATED IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA MANUAL IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA HOSPITALS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA DIAGNOSTIC LABORATORIES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA CLINICS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA ACADEMIC INSTITUTES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA OTHERS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA DIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA INDIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 41 SAUDI ARABIA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 42 SAUDI ARABIA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 43 SAUDI ARABIA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 44 SAUDI ARABIA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 45 SAUDI ARABIA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 46 SAUDI ARABIA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 47 SAUDI ARABIA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 48 SAUDI ARABIA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 49 SOUTH AFRICA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 SOUTH AFRICA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 51 SOUTH AFRICA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 52 SOUTH AFRICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 53 SOUTH AFRICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 54 SOUTH AFRICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 55 SOUTH AFRICA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 56 SOUTH AFRICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 57 EGYPT DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 58 EGYPT DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 EGYPT ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 EGYPT CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 61 EGYPT DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 62 EGYPT DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 63 EGYPT DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 64 EGYPT DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 65 U.A.E. DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 66 U.A.E. DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 67 U.A.E. ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 68 U.A.E. CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 69 U.A.E. DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 70 U.A.E. DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 71 U.A.E. DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 72 U.A.E. DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 73 ISRAEL DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 74 ISRAEL DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 75 ISRAEL ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 76 ISRAEL CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 77 ISRAEL DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 78 ISRAEL DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 79 ISRAEL DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 80 ISRAEL DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 81 REST OF MIDDLE EAST & AFRICA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390